Tyler Weaver, MD
Otolaryngology · Oregon City, ORNPI 1326467812
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Stryker at 32.5% of the total. Reporting peaked in 2019 at $555 and has fallen 68.9% since, to $172 in 2025.
Across 15 payments — averaging $55.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$272
- Smith+Nephew$180
- Sanofi$144
- Regeneron Healthcare Solutions, Inc.$103
- Baxter Healthcare$36
- Acclarent, Inc$30
- plus $73 from 3 others
What the payments were for
- Food & beverage$38646%
- Education$45254%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $272 |
| Smith+Nephew | 1 | $180 |
| Sanofi | 6 | $144 |
| Regeneron Healthcare Solutions, Inc. | 1 | $103 |
| Baxter Healthcare | 1 | $36 |
| Acclarent, Inc | 2 | $30 |
| GSK | 1 | $30 |
| Vertex | 1 | $27 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UNIVERSAL MANDIBLE$272
- Coblation Wands$180
- LIBTAYO$103
How this compares
$838 in reported general payments places this provider in the 60th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 60 | $1,967 |
| Omeprazole | 103 | $1,457 |
| Azelastine Hcl | 50 | $1,402 |
| Esomeprazole Magnesium | 57 | $1,164 |
| Dexamethasone Sodium Phosphate | 16 | $757 |
| Fluticasone Propionate | 48 | $655 |
| Montelukast Sodium | 39 | $504 |
| Pantoprazole Sodium | 40 | $360 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $247 |
| Doxycycline Hyclate | 13 | $242 |
| Ciprofloxacin Hcl | 16 | $208 |
| Ofloxacin | 14 | $126 |
| Levothyroxine Sodium | 17 | $103 |
| Prednisone | 26 | $62 |
| Oxycodone Hcl | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Oregon City
- Kelly RydlundOregon City$734
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Andrew BakerMilwaukie$8K
- Daniel ClayburghPortland$7K
- Timothy HullarPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.